Researchers at Aarhus University have discovered why a specific gene, APOE4, significantly increases the risk of developing Alzheimer’s disease – a finding that could pave the way for future treatments, though testing for the gene is not currently recommended.
Breakthrough in Understanding Alzheimer’s Risk Gene
Scientists at Aarhus University in Denmark have uncovered a crucial mechanism that explains why individuals with the APOE4 gene are at much higher risk of developing Alzheimer’s disease. While it has long been known that APOE4 is a major genetic risk factor, the new research pinpoints the biological process behind this elevated vulnerability, offering a foundation for potential treatment options in the future.
Globally, approximately 24 percent of the population carries at least one copy of the APOE4 gene. Around 2 to 3 percent have two copies, putting them in the highest risk category. In Denmark alone, it’s estimated that up to 1.5 million people may carry at least one copy of the gene.
How APOE4 Affects the Brain
The study conducted by the Danish research team explains that as people age, brain cells become less capable of deriving energy from glucose. Normally, to compensate, these cells shift to using alternative fuel sources like lipids, including fats. However, those with the APOE4 gene face a significant obstacle in this adaptive process.
The APOE4 gene variant impairs the ability of aging brain cells to switch to using lipids for energy. Without this alternative fuel source, the cells struggle to function, leading to a gradual decline in brain performance, and in turn, increasing the risk of Alzheimer’s.
No Immediate Benefits in Genetic Testing
Despite the importance of the discovery, experts at Aarhus University advise against seeking genetic testing for APOE4 at this stage. There is currently no treatment available that can offset the elevated risk associated with carrying the gene. Health practitioners caution that simply knowing one’s genetic risk does not provide actionable medical steps and may lead to unnecessary anxiety.
Hope for Future Treatments
Although no cure for Alzheimer’s exists today, the latest findings offer promising new directions for medicinal research. Scientists now intend to explore how they can support the brain’s ability to utilize lipids more efficiently. Existing drugs that influence lipid metabolism may hold potential for slowing down or even preventing Alzheimer’s in individuals who carry APOE4.
Alzheimer’s Cases are Expected to Climb
According to Denmark’s Dementia Knowledge Center, roughly 100,000 Danes over the age of 65 are currently living with some form of dementia. That number is projected to rise to more than 145,000 by 2040 due to the aging population. Understanding the relationship between genes like APOE4 and brain function is becoming increasingly important as societies grapple with the growing healthcare burden posed by neurodegenerative diseases.
Globally, it is estimated that 163 million people carry two copies of the APOE4 gene, putting them at the highest risk level. Public awareness of the gene has grown in recent years, particularly after Australian actor Chris Hemsworth revealed that he carries two copies and that his father was recently diagnosed with early-stage Alzheimer’s disease.
Preventive Lifestyle Measures Still Matter
While APOE4 significantly raises genetic susceptibility, researchers emphasize that carrying the gene does not guarantee the onset of Alzheimer’s. Lifestyle factors play a vital role in determining who ultimately develops the disease. Regular physical activity, intellectual engagement, and a healthy diet are all proven ways to reduce dementia risk in the general population.
It’s a hopeful message that even those with APOE4 can take steps to maintain brain function. The common saying among Alzheimer’s researchers is that “you can outrun Alzheimer’s,” underscoring the importance of staying physically and mentally active regardless of genetic predisposition.
No Silver Bullet for Alzheimer’s Yet
Experts stress that Alzheimer’s is a complex condition with multiple contributing factors, and there’s unlikely to be a single miracle cure. Instead, scientists envision a future where various interconnected treatments can tackle different elements of the disease – such as genetic risk, amyloid plaques, inflammation, and metabolic dysfunction.
The latest research from Aarhus University marks a significant leap forward in tackling one of the disease’s most mysterious genetic components. With more scientific effort, the hope is that targeted therapies could one day delay or prevent the progression of Alzheimer’s in high-risk individuals, marking a turning point in the fight against one of the world’s most devastating neurological disorders.
